Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in metastatic colorectal cancer (France, FFCD) – Phase 2
2016-001225-13Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Jun 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of bevacizumab in colorectal cancer (CRC), sponsored by Fédération Francophone de Cancérologie Digestive. Started Jun 2016; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2016-001225-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001225-13.